Fred Kurland - Net Worth and Insider Trading
Fred Kurland Net Worth
The estimated net worth of Fred Kurland is at least $170,550 dollars as of 2024-04-26. Fred Kurland is the CFO of Corcept Therapeutics Inc and owns about 7,500 shares of Corcept Therapeutics Inc (CORT) stock worth over $170,550. Details can be seen in Fred Kurland's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Fred Kurland has not made any transactions after 2005-12-20 and currently still holds the listed stock(s).
Transaction Summary of Fred Kurland
Fred Kurland Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fred Kurland owns 5 companies in total, including Aridis Pharmaceuticals Inc (ARDS) , XOMA Corp (XOMA) , and Corcept Therapeutics Inc (CORT) among others .
Click here to see the complete history of Fred Kurland’s form 4 insider trades.
Insider Ownership Summary of Fred Kurland
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARDS | Aridis Pharmaceuticals Inc | 2018-08-13 | Chief Financial Officer |
| XOMA | XOMA Corp | 2013-11-13 | CFO & VP Finance |
| CORT | Corcept Therapeutics Inc | 2005-12-20 | Chief Financial Officer |
| GTOPQ | Genitope Corp | 2003-10-28 | CFO |
| XOMAO.PFD | XOMA Corp | 2013-11-13 | CFO & VP Finance |
Fred Kurland Latest Holdings Summary
Fred Kurland currently owns a total of 1 stock. Fred Kurland owns 7,500 shares of Corcept Therapeutics Inc (CORT) as of December 20, 2005, with a value of $170,550.
Latest Holdings of Fred Kurland
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 2005-12-20 | 7,500 | 22.74 | 170,550 |
Holding Weightings of Fred Kurland
Fred Kurland Form 4 Trading Tracker
According to the SEC Form 4 filings, Fred Kurland has made a total of 0 transactions in Corcept Therapeutics Inc (CORT) over the past 5 years. The most-recent trade in Corcept Therapeutics Inc is the acquisition of 2,500 shares on December 20, 2005, which cost Fred Kurland around $10,375.
Insider Trading History of Fred Kurland
- 1
Fred Kurland Trading Performance
GuruFocus tracks the stock performance after each of Fred Kurland's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fred Kurland is 19.82%. GuruFocus also compares Fred Kurland's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fred Kurland within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fred Kurland's insider trading performs compared to the benchmark.
Performance of Fred Kurland
Average Return
-37.09%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 31.21 | 19.82 | 6.13 | -37.09 | -36.28 | -23.98 |
| Relative Return to S&P 500(%) | 29.65 | 16.67 | 6.05 | -46.95 | -44.59 | -22.3 |
Fred Kurland Ownership Network
Ownership Network List of Fred Kurland
Ownership Network Relation of Fred Kurland
Fred Kurland Owned Company Details
What does Aridis Pharmaceuticals Inc do?
Who are the key executives at Aridis Pharmaceuticals Inc?
Fred Kurland is the Chief Financial Officer of Aridis Pharmaceuticals Inc. Other key executives at Aridis Pharmaceuticals Inc include 10 percent owner Fibrosis Foundation Cystic , Chief Medical Officer Hasan Jafri , and director & 10 percent owner & CEO & CSO & Director Vu Truong .
Aridis Pharmaceuticals Inc (ARDS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aridis Pharmaceuticals Inc (ARDS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aridis Pharmaceuticals Inc (ARDS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aridis Pharmaceuticals Inc (ARDS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aridis Pharmaceuticals Inc Insider Transactions
Fred Kurland Mailing Address
Above is the net worth, insider trading, and ownership report for Fred Kurland. You might contact Fred Kurland via mailing address: C/o Genitope Corp, 525 Penobscot Drive, Redwood City Ca 94063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
